Liu TT, Li CF, Tan KT, Jan YH, Lee PH, Huang CH, Yu SC, Tsao CF, Wang JC and Huang HY*. Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of H2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers 2022 Mar 31;14(7):1787.
Lee PH, Weng SW, Liu TT, Yu HL, Wang MC, Huang WT. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment. Exp Mol Pathol 2019 Oct;110:104294.
Wu CN, Liu TT, Yang CH, Hwang CF Current and future treatments for external auditory canal cancer. International Journal of Head and Neck Science 2019, 3(2): 78-91.
You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Co-First author)
Li CF, Liu TT, Wang JC, Yu SC, Chen YY, Fang FM, Li Ws, Huang HY. Hydroxysteroid 11- dehydrogenase 1 overexpression with copy-number gain and missense mutations in primary gastrointestinal stromal tumors. J Clin Med. 2018 Nov 1;7(11). pii: E408. doi: 10.3390/jcm7110408 (SCI, IF=5.583; General & internal, co-first author*)
Li CF, Liu TT, Chuang IC, Chen YY, Fu-Min Fang FM, Chan TC, Li WS, Huang HY. PLCB4 copy gain and PLCs4 overexpression in primary gastrointestinal stromal tumors: integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival. Oncotarget. 2017 Mar 21;8(12):19997-20010
Huang GK, Liu TT, Weng SW, You HL, Wei YC, Chen CH, Eng HL, Huang WT. CUL4A Overexpression as an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. BMC Cancer (2017) 17:395 DOI 10.1186/s12885-017-3389-z (Co-first author)
Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.
Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma.
